SCHEMBL29328366

SCHEMBL29328366

COC(=O)c1ccc(C2CC(=O)N(C)CCN2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.44
HSD17B10 Q99714 3/20 0.43
TSHR P16473 3/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 3/20 0.41
GAA P10253 2/20 0.41
HPGD P15428 2/20 0.41
CASP1 P29466 2/20 0.41
CASP7 P55210 2/20 0.41
ATM Q13315 2/20 0.41
GLA P06280 1/20 0.41
GPBAR1 Q8TDU6 2/20 0.40
TP53 P04637 1/20 0.40
MAPK1 P28482 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
OPRD1 P41143 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30109134 0.80 MEN1 (0.49) HTTHSD17B10TSHRMEN1KMT2A
SCHEMBL31269595 0.80 MEN1 (0.49) HTTHSD17B10TSHRMEN1KMT2A
SCHEMBL29328207 0.79 MEN1 (0.45) HTTHSD17B10TSHRMEN1KMT2A
Hydrochloric Acid SCHEMBL31056797 0.78 MEN1 (0.44) HTTHSD17B10TSHRMEN1KMT2A
SCHEMBL29328399 0.77 HTT (0.50) HTTHSD17B10TSHRMEN1KMT2A
SCHEMBL29328435 0.77 HSD17B10 (0.43) HTTHSD17B10TSHRMEN1KMT2A
SCHEMBL30109178 0.76 HSD17B10 (0.45) HTTHSD17B10TSHRMEN1KMT2A
SCHEMBL31269573 0.76 HSD17B10 (0.45) HTTHSD17B10TSHRMEN1KMT2A
SCHEMBL30109301 0.75 EP300 (0.45) HTTHSD17B10TSHRMEN1KMT2A
SCHEMBL24835240 0.74 HSD17B10 (0.49) HTTHSD17B10TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed